In vivo assessment of nanostructured lipid carrier for oral delivery of zerumbone in leukemic mice model

Cancer nanotherapeutics are progressing rapidly with innovative drug delivery systems to replace conventional delivery systems. Although, antitumor activity of zerumbone (ZER) has been reported, there has been no available information of ZER-loaded nanostructured lipid carrier (NLC) affects murine l...

Full description

Bibliographic Details
Main Authors: Rahman, Heshu Sulaiman, Abdullah, R., Othman, Hemn Hassan, Chartrand, Max Stanley, Abdul, Ahmad Bustamam, Ajdari, Zahra, Hosseinpour, Mahnaz, Abdul Samad, Nozlena
Format: Conference or Workshop Item
Language:English
Published: UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience 2014
Online Access:http://psasir.upm.edu.my/id/eprint/17228/
http://psasir.upm.edu.my/id/eprint/17228/1/ABSTRACT%20CAC%202014_2%20medic%2012.pdf
_version_ 1848843183411167232
author Rahman, Heshu Sulaiman
Abdullah, R.
Othman, Hemn Hassan
Chartrand, Max Stanley
Abdul, Ahmad Bustamam
Ajdari, Zahra
Hosseinpour, Mahnaz
Abdul Samad, Nozlena
author_facet Rahman, Heshu Sulaiman
Abdullah, R.
Othman, Hemn Hassan
Chartrand, Max Stanley
Abdul, Ahmad Bustamam
Ajdari, Zahra
Hosseinpour, Mahnaz
Abdul Samad, Nozlena
author_sort Rahman, Heshu Sulaiman
building UPM Institutional Repository
collection Online Access
description Cancer nanotherapeutics are progressing rapidly with innovative drug delivery systems to replace conventional delivery systems. Although, antitumor activity of zerumbone (ZER) has been reported, there has been no available information of ZER-loaded nanostructured lipid carrier (NLC) affects murine leukemia cells in vivo. In a previous study, ZER was incorporated into NLC by high pressure homogenization (HPH) technique. Physicochemical characterization included particle size, polydipersity index, zeta potential, pH, entrapment efficiency, loading capacity, stability study, and in vitro drug release, as well as physicochemical stability after being autoclaved and stored at 4˚C, 25˚C and 40˚C for 1 month, were examined. In this study, in vivo effects of ZER-NLC on murine leukemia WEHI-3B cells were investigated. The outcomes of histopathology, TEM and TUNEL assays of BALB/c leukemia mice revealed that the number of leukemia cells were significantly (P < 0.05) decreased in spleen tissue after four weeks of oral administration of ZER-NLC. In conclusion, NLC is suggested as a promising carrier for ZER oral delivery.
first_indexed 2025-11-15T08:10:59Z
format Conference or Workshop Item
id upm-17228
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T08:10:59Z
publishDate 2014
publisher UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience
recordtype eprints
repository_type Digital Repository
spelling upm-172282016-04-26T03:53:42Z http://psasir.upm.edu.my/id/eprint/17228/ In vivo assessment of nanostructured lipid carrier for oral delivery of zerumbone in leukemic mice model Rahman, Heshu Sulaiman Abdullah, R. Othman, Hemn Hassan Chartrand, Max Stanley Abdul, Ahmad Bustamam Ajdari, Zahra Hosseinpour, Mahnaz Abdul Samad, Nozlena Cancer nanotherapeutics are progressing rapidly with innovative drug delivery systems to replace conventional delivery systems. Although, antitumor activity of zerumbone (ZER) has been reported, there has been no available information of ZER-loaded nanostructured lipid carrier (NLC) affects murine leukemia cells in vivo. In a previous study, ZER was incorporated into NLC by high pressure homogenization (HPH) technique. Physicochemical characterization included particle size, polydipersity index, zeta potential, pH, entrapment efficiency, loading capacity, stability study, and in vitro drug release, as well as physicochemical stability after being autoclaved and stored at 4˚C, 25˚C and 40˚C for 1 month, were examined. In this study, in vivo effects of ZER-NLC on murine leukemia WEHI-3B cells were investigated. The outcomes of histopathology, TEM and TUNEL assays of BALB/c leukemia mice revealed that the number of leukemia cells were significantly (P < 0.05) decreased in spleen tissue after four weeks of oral administration of ZER-NLC. In conclusion, NLC is suggested as a promising carrier for ZER oral delivery. UPM-MAKNA Cancer Research Laboratory, Institute of Bioscience 2014 Conference or Workshop Item PeerReviewed application/pdf en http://psasir.upm.edu.my/id/eprint/17228/1/ABSTRACT%20CAC%202014_2%20medic%2012.pdf Rahman, Heshu Sulaiman and Abdullah, R. and Othman, Hemn Hassan and Chartrand, Max Stanley and Abdul, Ahmad Bustamam and Ajdari, Zahra and Hosseinpour, Mahnaz and Abdul Samad, Nozlena (2014) In vivo assessment of nanostructured lipid carrier for oral delivery of zerumbone in leukemic mice model. In: Scientific Cancer Research Poster Competition in conjunction with Cancer Awareness Carnival 2014, 10 May 2014, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia. .
spellingShingle Rahman, Heshu Sulaiman
Abdullah, R.
Othman, Hemn Hassan
Chartrand, Max Stanley
Abdul, Ahmad Bustamam
Ajdari, Zahra
Hosseinpour, Mahnaz
Abdul Samad, Nozlena
In vivo assessment of nanostructured lipid carrier for oral delivery of zerumbone in leukemic mice model
title In vivo assessment of nanostructured lipid carrier for oral delivery of zerumbone in leukemic mice model
title_full In vivo assessment of nanostructured lipid carrier for oral delivery of zerumbone in leukemic mice model
title_fullStr In vivo assessment of nanostructured lipid carrier for oral delivery of zerumbone in leukemic mice model
title_full_unstemmed In vivo assessment of nanostructured lipid carrier for oral delivery of zerumbone in leukemic mice model
title_short In vivo assessment of nanostructured lipid carrier for oral delivery of zerumbone in leukemic mice model
title_sort in vivo assessment of nanostructured lipid carrier for oral delivery of zerumbone in leukemic mice model
url http://psasir.upm.edu.my/id/eprint/17228/
http://psasir.upm.edu.my/id/eprint/17228/1/ABSTRACT%20CAC%202014_2%20medic%2012.pdf